Clinicopathological Role of Serum-Derived Hyaluronan-Associated Protein (SHAP)-Hyaluronan Complex in Endometrial Cancer

Overview

Journal Obstet Gynecol Int

Publisher Wiley

Specialty Gynecology & Obstetrics

Date 2011 Sep 10

PMID 21904555

Citations 7

Authors

Hiromitsu Yabushita

Keita Iwasaki

Kouhei Kanyama

Yukihiko Obayashi

Lisheng Zhuo

Naoki Itano

Koji Kimata

Akihiko Wakatsuki

Affiliations

Soon will be listed here.

Abstract

The role of hyaluronan (HA), serum-derived HA-associated protein (SHAP)-HA complex and hyaluronan synthase (HAS) in endometrial carcinomas was investigated. The relationship of metalloproteinase (MMP) and its inhibitor (TIMP) with HA and the SHAP-HA complex was also examined. The expression of HAS1 was related to the depth of myometrial invasion and lymph-vascular space involvement. The serum levels of HA, SHAP-HA complex, MMP-9, and TIMP-1 were increased in related with the depth of myometrial invasion, histological grade and lymph-vascular space involvement. They were also higher in the HAS1-positive group compared to -negative group. The serum concentrations of HA and SHAP-HA complex had a significant correlation with the MMP-9 and TIMP-1. The patients with elevated SHAP-HA complex had the shorter disease-free survival. The multivariate analysis revealed that the SHAP-HA complex was the independent variable for disease-free survival of endometrial cancer patients. In conclusion, the elevation of serum SHAP-HA complex depended on the HAS1 expression and the SHAP-HA complex is a useful marker to predict disease recurrence in endometrial cancer patients. The SHAP-HA complex may promote the lymph-vascular space involvement and the synthesis and activation of MMP-9 and TIMP-1 in the progression of endometrial cancer.

Citing Articles

Hyaluronic Acid Interacting Molecules Mediated Crosstalk between Cancer Cells and Microenvironment from Primary Tumour to Distant Metastasis.

Xu Y, Benedikt J, Ye L Cancers (Basel). 2024; 16(10).

PMID: 38791985 PMC: 11119954. DOI: 10.3390/cancers16101907.

Screening and identification of key genes and pathways in metastatic uveal melanoma based on gene expression using bioinformatic analysis.

Xie J, Wu Z, Xu X, Liang G, Xu J Medicine (Baltimore). 2020; 99(43):e22974.

PMID: 33120861 PMC: 7581038. DOI: 10.1097/MD.0000000000022974.

Human hyaluronic acid synthase-1 promotes malignant transformation via epithelial-to-mesenchymal transition, micronucleation and centrosome abnormalities.

Nguyen N, Kumar A, Chacko S, Ouellette R, Ghosh A Cell Commun Signal. 2017; 15(1):48.

PMID: 29137675 PMC: 5686803. DOI: 10.1186/s12964-017-0204-z.

Hyaluronan expression in primary and secondary brain tumors.

Jadin L, Pastorino S, Symons R, Nomura N, Jiang P, Juarez T Ann Transl Med. 2015; 3(6):80.

PMID: 25992379 PMC: 4416955. DOI: 10.3978/j.issn.2305-5839.2015.04.07.

Therapeutic targeting of hyaluronan in the tumor stroma.

Kultti A, Li X, Jiang P, Thompson C, Frost G, Shepard H Cancers (Basel). 2013; 4(3):873-903.

PMID: 24213471 PMC: 3712709. DOI: 10.3390/cancers4030873.

References

Laurent T, Fraser J . Hyaluronan. FASEB J. 1992; 6(7):2397-404. View

Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R, Lipponen P . Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res. 1998; 58(2):342-7. View

Mroczko B, Groblewska M, Okulczyk B, Kedra B, Szmitkowski M . The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients. Int J Colorectal Dis. 2010; 25(10):1177-84. PMC: 2928442. DOI: 10.1007/s00384-010-0991-9. View

Mast B, Diegelmann R, Krummel T, Cohen I . Scarless wound healing in the mammalian fetus. Surg Gynecol Obstet. 1992; 174(5):441-51. View

Murate T, Hayakawa T . Multiple functions of tissue inhibitors of metalloproteinases (TIMPs): new aspects in hematopoiesis. Platelets. 2006; 10(1):5-16. DOI: 10.1080/09537109976293. View

Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M . Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem. 1999; 274(35):25085-92. DOI: 10.1074/jbc.274.35.25085. View

Morrow C, Bundy B, Kurman R, Creasman W, Heller P, Homesley H . Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991; 40(1):55-65. DOI: 10.1016/0090-8258(91)90086-k. View

Peng S, Su C, Kuo C, Shaw C, Wang H . CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis. Int J Oncol. 2007; 31(5):1119-26. View

Isnard N, Legeais J, Renard G, Robert L . Effect of hyaluronan on MMP expression and activation. Cell Biol Int. 2001; 25(8):735-9. DOI: 10.1006/cbir.2001.0759. View

10.

Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T . Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J Immunol Methods. 1990; 127(1):103-8. DOI: 10.1016/0022-1759(90)90345-v. View

11.

Anttila M, Tammi R, Tammi M, Syrjanen K, Saarikoski S, Kosma V . High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res. 2000; 60(1):150-5. View

12.

Murray D, Morrin M, McDonnell S . Increased invasion and expression of MMP-9 in human colorectal cell lines by a CD44-dependent mechanism. Anticancer Res. 2004; 24(2A):489-94. View

13.

Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawaguchi K . Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Oncol Rep. 2002; 10(1):89-95. View

14.

Kayastha S, Freedman A, Piver M, Mukkamalla J, Werness B . Expression of the hyaluronan receptor, CD44S, in epithelial ovarian cancer is an independent predictor of survival. Clin Cancer Res. 1999; 5(5):1073-6. View

15.

Zhang M, Zhu G, Gao H, Zhao S, Xue Y . Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma. J Surg Oncol. 2011; 103(3):243-7. DOI: 10.1002/jso.21824. View

16.

Huang L, Yoneda M, Kimata K . A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor. J Biol Chem. 1993; 268(35):26725-30. View

17.

Yamada Y, Itano N, Narimatsu H, Kudo T, Morozumi K, Hirohashi S . Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer. Clin Exp Metastasis. 2004; 21(1):57-63. DOI: 10.1023/b:clin.0000017203.71293.e0. View

18.

Knudson W . Tumor-associated hyaluronan. Providing an extracellular matrix that facilitates invasion. Am J Pathol. 1996; 148(6):1721-6. PMC: 1861627. View

19.

Alaniz L, Garcia M, Cabrera P, Arnaiz M, Cavaliere V, Blanco G . Modulation of matrix metalloproteinase-9 activity by hyaluronan is dependent on NF-kappaB activity in lymphoma cell lines with dissimilar invasive behavior. Biochem Biophys Res Commun. 2004; 324(2):736-43. DOI: 10.1016/j.bbrc.2004.09.120. View

20.

Kanomata N, Yokose T, Kamijo T, Yonou H, Hasebe T, Itano N . Hyaluronan synthase expression in pleural malignant mesotheliomas. Virchows Arch. 2005; 446(3):246-50. DOI: 10.1007/s00428-004-1197-8. View